---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-021653"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2022-08-08T23:59:59+00:00"
generated_at: "2026-06-24T02:45:54.518413+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed Q2 revenue $33.0M (+1% YoY); GAAP net income falls 75% to $1.9M

## Summary
- Revenue $33.0M vs $32.6M year ago; gross margin dropped to 45% from 60%.
- GAAP net income $1.9M vs $7.6M; Non-GAAP Adjusted EBITDA $8.9M vs $13.9M.
- Working capital declined to $8.9M from $13.9M; no guidance provided.
- CEO cited increased dispensary traffic despite industry headwinds and 40-year high inflation.

## SEC filing metadata
- accession: 0001493152-22-021653
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2022-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000149315222021653/0001493152-22-021653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000149315222021653/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-021653
- JSON: https://secwatch.observer/filing/0001493152-22-021653.json
- Plain text: https://secwatch.observer/filing/0001493152-22-021653.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.